Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
about
Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and managementMitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysisFatty Acid Beta-Oxidation Disorders: A Brief ReviewDynamic simulations on the mitochondrial fatty acid beta-oxidation network.Increasing protein at the expense of carbohydrate in the diet down-regulates glucose utilization as glucose sparing effect in ratsPregnancy-related liver disorders.Metabolite profiling identifies markers of uremia.Use of propofol for short duration procedures in children with long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiencies.¹H-NMR and MS based metabolomics study of the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet.(1) H NMR Metabolic Profiling of Biofluids from Rats with Gastric Mucosal Lesion and Electroacupuncture TreatmentChemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis.Chinese medicine formula lingguizhugan decoction improves Beta-oxidation and metabolism of Fatty Acid in high-fat-diet-induced rat model of Fatty liver disease.Mechanism-based bioanalysis and biomarkers for hepatic chemical stress.Management of an LCHADD Patient During Pregnancy and High Intensity Exercise.Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands.Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.Recent perspectives of pediatric mitochondrial diseases.Targeted metabolomics: new insights into pathobiology of retained placenta in dairy cows and potential risk biomarkers.Mitochondrial Fatty Acid Oxidation Disorders Associated with Short-Chain Enoyl-CoA Hydratase (ECHS1) Deficiency.Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid β-oxidation disorders in adult patients with rhabdomyolysis
P2860
Q24616340-54E8B4B8-0236-457B-801B-D59D4E487A7CQ24630557-BD81D9E3-85E5-4282-82A8-6ECCB6A11505Q26741021-F02CD4FF-C055-4021-AB35-82CDDE3A737FQ33397846-EA69F75D-A7CE-4D4C-A643-5D7361A6F5A3Q33822290-AE5BFB3C-F428-4C0A-A39C-9E9AFC97FCBEQ33978151-A0A5E73A-71E7-45D0-ACC0-890D03E3CF44Q33979275-D027ABC6-0928-4617-8B24-309F1C08779CQ34001740-2199B639-3A37-4B95-B203-936E3FAF8224Q35192566-06FC78B8-B99B-4A60-8037-614299E19424Q35797805-FF3BB699-0138-483D-8EE7-4D2C78181625Q35843679-33905459-9929-41F5-80C9-E133B71905D0Q36879157-DBD68918-1A5B-4704-939A-27D3E9BCF8F7Q37557613-CD313AEF-FE26-45A8-9707-3E76547C5410Q37707138-78C7397D-F586-4156-882E-8A761D6B70E3Q38026944-980655AC-64D0-47A5-80B0-0295A413199CQ43776338-9DF96032-7E25-4816-A13C-0CC7925A8629Q47133616-74F23F47-7FB6-45D4-94EA-2ECF4AC342E4Q47645894-E6622E7A-DD8D-4193-820E-B6AEAC20B2BFQ47896942-BB9B8E8C-85E9-459C-A748-98681DDD1531Q55515392-A09AC65D-1439-46E6-A6F1-7C542228D3EAQ56856142-5FFAFA41-C326-4C15-8D9F-9F321EE34744
P2860
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@ast
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@en
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@nl
type
label
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@ast
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@en
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@nl
prefLabel
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@ast
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@en
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@nl
P2093
P1433
P1476
Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
@en
P2093
Bridget Wilcken
Judith Hammond
Keow G Sim
P356
10.1016/S0009-8981(02)00182-1
P577
2002-09-01T00:00:00Z